Whitecap Resources (OTCPK:SPGY.F) 2026 Investor Day Transcript
2026-01-05 16:02
Summary of Whitecap Resources Investor Day Conference Call Company Overview - **Company**: Whitecap Resources - **Market Capitalization**: CAD 14 billion - **Enterprise Value**: CAD 17 billion - **Daily Production**: Approximately 372,500 BOE (Barrels of Oil Equivalent) per day, ranking as the seventh largest Canadian oil and natural gas producer - **Natural Gas Production**: 900 million cubic feet per day, making it the fifth largest gas producer in Canada - **2026 Capital Investment Plan**: CAD 2-2.1 billion, projected to generate approximately CAD 3.3 billion of funds flow at $60 WTI and $3 AECO prices [7][8] Strategic Focus - **Capital Allocation**: Aimed at generating strong, durable returns for shareholders through disciplined investment and operational excellence [5][6] - **Competitive Advantages**: - High-quality inventory with depth and commodity optionality - Technical excellence and strong execution - Capital discipline to protect and compound shareholder value - Strong balance sheet to manage risk and maintain flexibility [6][7] Financial Health - **Net Debt**: CAD 3.3 billion, with a debt-to-funds flow ratio of 1:1 - **Dividend**: CAD 0.73 per share, yielding approximately 6-6.5% at current share price - **Targeted Annual Total Return**: 10-15% for shareholders [9][10] Asset Overview - **Asset Types**: Divided into unconventional (Montney and Duvernay) and conventional assets - **Unconventional Assets**: - 4,700 drilling locations with significant growth potential - Producing approximately 245,000 BOE per day, generating around CAD 900 million in annual free funds flow at current pricing [21][23] - **Conventional Assets**: - Producing about 140,000 BOE per day, primarily oil and NGLs - 5,800 locations with a multi-decade inventory, including enhanced oil recovery projects [58][59] Operational Achievements - **Technical Improvements**: Continuous enhancements in drilling and completion efficiency, leading to improved well performance and reduced costs [49][50][51] - **Production Optimization**: Focus on base production optimization, resulting in significant uplifts in production rates [56][57] Growth Potential - **Unconventional Division**: - Strong long-term growth and free funds flow potential - Flexibility across commodity types allows for capital allocation based on market signals [21][22][25] - **Duvernay Position**: - Largest landholder with approximately 500,000 acres and 700 identified locations - Expected to generate CAD 650 million-CAD 850 million in annual asset-level free cash flow once stabilized [26][30] - **Montney Position**: - Approximately one million acres with diverse development options, providing long-dated organic growth potential [31][32] Capital Efficiency and Execution - **Development Workflow**: A collaborative process that integrates geological evaluations, development planning, economic assessments, and execution to optimize returns [44] - **Design Optimization**: Successful implementation of strategies that improve capital efficiency and returns across various projects [45][46][47] Conclusion - **Long-Term Vision**: Whitecap Resources aims to leverage its strong asset base, disciplined capital allocation, and operational excellence to deliver sustainable shareholder returns and maintain a competitive edge in the energy sector [60][61]
GF-PCB update
2026-01-05 15:42
Sector Report Summary: Technology Company and Industry Overview - The report focuses on the **PCB (Printed Circuit Board)** industry, particularly in relation to **Nvidia** and **ASIC (Application-Specific Integrated Circuit)** platforms [2][3]. Core Insights and Arguments - **Performance Comparison**: PCB names underperformed compared to optics in Q4 2025, but a recovery is expected starting Q1 2026 due to recent developments, including PCB scaling and Nvidia's Kyber backplane [2]. - **Scaling Trends**: PCB scaling is anticipated to be an inevitable trend over the next 2-3 years for both Nvidia and ASIC platforms, despite concerns regarding optics [3]. - **Material Preferences**: The report expresses a positive outlook on **EMC** for M9 leadership, **HVLP4 copper material** due to tight supply and demand, and PCB drills due to increased usage and price hikes [4]. - **Market Forecast**: The AI PCB market's Total Addressable Market (TAM) is projected to reach **RMB 28.4 billion** in 2025, **RMB 89.8 billion** in 2026, and **RMB 184.4 billion** in 2027, with additional demand from optical modules and switches [6]. - **M9 Adoption**: M9 adoption is expected to extend to ASIC programs starting in 2027, with EMC being the only qualified supplier for M9 [6]. Risks Identified - **Demand Deceleration**: Potential deceleration in AI demand poses a risk [5]. - **Geopolitical Impact**: Geopolitical factors could affect the industry [5]. - **Competition**: Increased competition within the PCB market is a concern [5]. Additional Important Insights - **Supply Chain Dynamics**: AWS's T3 liquid cooling version will adopt an architecture similar to Nvidia's Oberon, indicating growth in PCB/CCL content per chip [6]. - **Quality Issues**: Quality issues with Mitsui Mining's HVLP copper fill at EMC have led to Co-tech becoming a preferred supplier [6]. - **Price Trends**: Drill prices have increased by **15%** starting January 2026 due to tight capacity and rising raw material costs [6]. - **Order Increases**: Monthly orders from Victoria Giant to Dtech have quadrupled in January compared to November, reaching approximately **90 million units** per month [6]. Conclusion The report indicates a positive outlook for the PCB industry, particularly with the anticipated growth in AI applications and the strategic developments involving major players like Nvidia and AWS. However, potential risks such as demand deceleration and geopolitical impacts should be monitored closely.
Crinetics Pharmaceuticals (NasdaqGS:CRNX) Update / Briefing Transcript
2026-01-05 14:32
Crinetics Pharmaceuticals (NasdaqGS:CRNX) Update / Briefing January 05, 2026 08:30 AM ET Company ParticipantsCatherine Novack - Director of Healthcare Equity ResearchToby Schilke - CFOAlex Thompson - Managing DirectorGayathri Diwakar - Head of Investor RelationsJon Wolleben - Managing DirectorJoe Schwartz - Senior Managing Director of Rare DiseasesIsabel Kalofonos - CCOGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGarnet Howells - VP of Global Product LeaderAlan Krasner - Chief End ...
Neumora Therapeutics (NasdaqGS:NMRA) Update / Briefing Transcript
2026-01-05 14:02
Neumora Therapeutics (NasdaqGS:NMRA) Conference Call Summary Company Overview - **Company**: Neumora Therapeutics - **Focus**: Development of NMRA-511 for Alzheimer's disease agitation Key Industry Insights - **Alzheimer's Disease Agitation**: Affects over 70% of individuals with Alzheimer's disease dementia, leading to increased caregiver stress and earlier placement in long-term care facilities [4][5] - **Unmet Need**: Significant unmet need for effective treatments in this area due to current products having tolerability issues and limited efficacy [5] Core Findings from Phase 1B Study - **Study Objective**: To evaluate the clinical effect of NMRA-511 in Alzheimer's disease agitation [3] - **Effect Size**: NMRA-511 demonstrated a compelling effect size, similar to Auvelity in the total population and more pronounced in patients with elevated anxiety [5][15] - **Safety Profile**: NMRA-511 showed a favorable safety and tolerability profile, with a low discontinuation rate due to adverse events at 2.5% [16] Detailed Study Results - **CMAI Total Score Reduction**: - Modified analysis set: 15.7 points reduction at week eight [13] - Elevated anxiety population: 20.1 points reduction at week eight, with a Cohen's D effect size of 0.51 to 0.64, considered unsurpassed in AD agitation [15] - **Aggression Subscore**: Notable reduction of 5.3 points in the aggression subscore, important for caregiver safety [14] Future Development Plans - **Next Steps**: - Initiate a MAD extension cohort in 2026 to explore higher doses [17] - Transition to a once-daily extended-release formulation, expected to enhance patient compliance and extend market exclusivity until 2046 [18] - Plan to initiate a phase two-three study for NMRA-511 in AD agitation following the MAD extension [18] Competitive Landscape - **Comparison with Other Treatments**: - NMRA-511 is positioned against Rexulti and Auvelity, with a focus on a better benefit-risk profile and improved tolerability [46][47] - Rexulti has faced challenges due to side effects and black box warnings, while NMRA-511 aims to avoid these issues [46] Market Opportunity - **Large Patient Population**: Nearly all Alzheimer's patients experience some form of agitation or anxiety, indicating a significant market opportunity for NMRA-511 [48] Additional Considerations - **Regulatory Strategy**: Potential for formal enrichment of patient populations based on baseline anxiety levels in future studies, following precedents set by other sponsors [27][28] - **Broader Indications**: Future exploration of NMRA-511 in other anxiety-related conditions, such as PTSD and autism, is considered [28] Conclusion - **Overall Sentiment**: The data from the phase 1B study provides confidence in the potential of NMRA-511 to address a high-impact medical need in Alzheimer's disease agitation, with plans for further development and exploration of broader indications [61]
Zenas BioPharma (NasdaqGS:ZBIO) Update / Briefing Transcript
2026-01-05 14:02
Summary of Zenas BioPharma Conference Call Company Overview - **Company**: Zenas BioPharma (NasdaqGS: ZBIO) - **Focus**: Development of obexelimab for the treatment of immunoglobulin G4-related disease (IgG4-RD) Key Industry Insights - **Disease Prevalence**: Estimated diagnosed prevalence of IgG4-RD in the U.S. is around 20,000 patients, with total prevalence (including undiagnosed) potentially reaching 40,000. Similar global prevalence is suggested [doc id='9'] - **Market Opportunity**: The market opportunity for IgG4-RD treatment is approximately $3 billion in the U.S. and $2 billion in Europe, with over half of diagnosed patients experiencing frequent flares [doc id='17'] Core Findings from INDIGO Trial - **Trial Results**: The INDIGO trial met its primary endpoint, showing a 56% reduction in the risk of IgG4-RD flare compared to placebo, with a hazard ratio of 0.443 and a p-value of 0.0005 [doc id='12'] - **Secondary Endpoints**: All four key secondary endpoints were met, including time to first flare and the proportion of patients achieving complete remission [doc id='13'] - **Safety Profile**: Obexelimab demonstrated a compelling safety and tolerability profile, with lower incidences of serious adverse events and infections compared to placebo [doc id='15] Treatment Advantages - **Mechanism of Action**: Obexelimab's unique inhibitory mechanism targets B-cells without depleting them, which may provide advantages over existing therapies like Uplizna [doc id='16'] - **Administration**: The drug is administered subcutaneously at home, aligning with patient preferences and reducing the need for infusion center visits [doc id='16'] - **Cost-Effectiveness**: The at-home administration model may lead to lower out-of-pocket costs for patients compared to high-priced infused therapies [doc id='17'] Future Plans - **Regulatory Submissions**: Plans to submit a Biologics License Application (BLA) to the U.S. FDA in Q2 and a marketing authorization application to the European Medicines Agency in the second half of the year [doc id='6'] - **Pipeline Expansion**: Zenas is advancing multiple candidates, including orelabrutinib and ZBO21, into clinical trials, aiming to establish a strong portfolio in autoimmune diseases [doc id='19'] Market Dynamics - **Underdiagnosis**: IgG4-RD is currently underdiagnosed, and the approval of obexelimab could enhance disease recognition and treatment [doc id='18'] - **Competitive Landscape**: The efficacy and safety profile of obexelimab positions it as a potential first-line therapy, especially for older patients who may not tolerate B-cell depletion [doc id='24'] Additional Insights - **KOL Feedback**: Key opinion leaders expressed enthusiasm for obexelimab's efficacy and safety, viewing it as a strong candidate for first-line treatment [doc id='23'] - **Payer Discussions**: Preliminary conversations with payers indicate a favorable view of obexelimab's risk-benefit profile, especially in comparison to existing therapies [doc id='49'] Conclusion - **Transformational Year**: 2025 was highlighted as a transformational year for Zenas, with the INDIGO results expected to drive momentum into 2026 and beyond [doc id='18']
Northern Star Resources (OTCPK:NESR.F) Update / Briefing Transcript
2026-01-05 04:02
Summary of Northern Star Resources Conference Call Company Overview - **Company**: Northern Star Resources (OTCPK:NESR.F) - **Date of Call**: January 04, 2026 Key Points Production Guidance - Annual production guidance revised down to **1.6-1.7 million ounces** from **1.7-1.85 million ounces** due to operational issues in December quarter [2][11] - Second-half production expected to be between **871,000-971,000 ounces** [2] Operational Challenges - **Kalgoorlie Production Centre** faced lower-than-expected production due to: - Partial suspension of mining at South Kalgoorlie operation due to a pit wall slip after significant rainfall [4] - Underperformance in processing at KCGM due to faults in the Fimiston primary crusher, resulting in a throughput shortfall of approximately **650,000 tons** [4][5] - **Yandal Production Centre** also experienced challenges: - Jundee faced structural failures in the crushing circuit, impacting processing by around **15,000 ounces** [8] - Thunderbox had reduced throughput and lower mine grades, affecting recovery rates [9][10] Financial Position - As of December 31, preliminary cash and bullion holdings are expected to be approximately **AUD 1.17 billion**, with total liquidity around **AUD 2.7 billion** [13] - Negative free cash flow anticipated in Q2 due to lower production and a **AUD 250 million** tax balancing payment [13] - All-in Sustaining Cost (AISC) per ounce expected to be higher in Q2 compared to Q1 due to lower production and increased sustaining capital [14] Future Outlook - Confidence in the underlying asset portfolio remains strong, with plans to commission the new Fimiston plant in six months, which is expected to enhance production and cost efficiency [3] - KCGM and South Kalgoorlie operations have returned to normal, with a focus on managing risks and capitalizing on opportunities [11][12] - The company is optimistic about the second half of FY 2026, with expectations of improved throughput and production [56] Maintenance and Operational Strategy - Emphasis on balancing sustaining capital investment with operational efficiency, particularly for aging assets [30] - Proactive maintenance strategy is in place to mitigate risks associated with aging equipment [28] Key Risks - Ongoing risks related to mill throughput at KCGM, which is critical for achieving production targets [18][36] - Potential for further operational disruptions due to weather or equipment failures, although recent issues are considered one-off events [56] Additional Insights - The company is managing a significant stockpile of high-grade material, which is expected to support production in the second half [57] - The Jundee airstrip upgrade is expected to improve operational efficiency by reducing flight interruptions [9] Conclusion - Northern Star Resources is navigating through operational challenges while maintaining a strong financial position. The company is focused on improving production efficiency and managing risks as it moves into the second half of FY 2026. The commissioning of the new Fimiston plant is anticipated to be a significant driver of future growth.
Bloomberg Businessweek-01.2026
2025-12-31 16:02
Summary of Key Points from the Conference Call Industry Overview - The focus is on the housing finance industry, specifically Virginia Housing, which manages a $16 billion mortgage portfolio and addresses the housing shortage in Virginia [8][9]. - The call also touches on the broader economic landscape, including the impact of artificial intelligence (AI) on various sectors, particularly technology and entertainment [25][52]. Virginia Housing - Virginia Housing aims to create 200,000 new homes to meet the employment needs of 350,000 new workers over the next decade [9]. - The agency collaborates with Wells Fargo for interest rate hedging, liquidity, and bond originations, which supports innovative housing solutions [9][10]. - The partnership with Wells Fargo is described as transformative, enabling Virginia Housing to explore programs like workforce housing and 3D-printed homes [10]. Economic Insights - The U.S. economy is experiencing a disconnect between lived experiences and economic data, with recession indicators flashing red but the economy continuing to grow [38][43]. - Analysts predict a 42% chance of a recession in 2026, with GDP growth forecasted at 2% [43][44]. - The labor market is stagnant, with low unemployment but also low hiring rates, creating a challenging environment for workers [44][47]. AI and Technology Sector - The tech industry is projected to spend nearly $1.2 trillion annually on data centers by 2030, raising concerns about a potential AI bubble [25][28]. - Companies like Oracle are heavily investing in AI infrastructure, raising $38 billion in debt for data centers, which could lead to financial instability if customer demand does not materialize [36][37]. - The AI sector is seen as a double-edged sword, driving economic growth while also posing risks of overvaluation and speculative investments [27][36]. Fast-Casual Dining Industry - The fast-casual dining sector is facing challenges, with companies like Sweetgreen and Chipotle reporting significant sales declines [76][77]. - Sweetgreen's sales fell 9.5% in Q3 2025, and Chipotle's shares dropped 40% for the year, indicating a shift in consumer spending habits [76][77]. - There is a growing trend of consumers opting for cheaper fast-food options, leading to speculation about the sustainability of the fast-casual model [78][82]. Consumer Behavior - The wealthiest 10% of consumers account for nearly half of all spending in the U.S., raising concerns about economic inequality [50][51]. - Price sensitivity is increasing among consumers, with many seeking value in their purchases, which could impact the pricing strategies of fast-casual restaurants [88][89]. Conclusion - The conference call highlights the interconnectedness of housing finance, economic trends, AI investments, and consumer behavior, suggesting a complex landscape for investors and companies alike as they navigate potential risks and opportunities in 2026 [43][52].
SpaceX Teaser_
2025-12-30 14:41
Summary of SpaceX Conference Call Company Overview - **Company**: SpaceX - **Industry**: Aerospace and Satellite Communications Key Points and Arguments 1. **Mars Colonization Plan**: SpaceX aims to build a self-sustaining city on Mars with a population of over one million, requiring the transport of millions of tons of goods to the planet [4][6][15] 2. **Launch Capacity**: SpaceX plans to conduct 10 launches per day, transporting over 200 tons of goods to low Earth orbit and 250,000 tons to Mars during each transfer window [4][6] 3. **Investment Highlights**: - Unique asset in the space industry with a potential growth trajectory of $10 trillion [7] - Long-term commitment from Elon Musk, a successful entrepreneur [7] - Strong ecosystem support from Tesla, xAI, Neuralink, and others [7] - Advanced reusable rocket technology, giving SpaceX a monopolistic position in launches [7] - Development of the largest low Earth orbit satellite constellation, Starlink, leveraging first-mover advantages [7] - High industrial manufacturing capabilities and vertical integration efficiency [7] Financial Overview 1. **Revenue Projections**: - Total revenue expected to grow from $8.6 billion in 2023 to $141.9 billion by 2040, with a CAGR of 53.5% from 2023 to 2024 [61] - Starlink expected to account for 74.6% of total revenue by 2040 [61] 2. **Operating Expenses**: Projected operating expenses will increase from $6.7 billion in 2023 to $49.5 billion by 2040 [61] 3. **Profitability**: Operating profit is expected to turn positive by 2024, reaching $68.6 billion by 2040 [61] 4. **Launch Frequency**: Total launches are projected to increase from 96 in 2023 to 556 by 2040 [61] Starlink Developments 1. **User Growth**: Starlink's user base is projected to grow significantly, reaching over 1 billion subscribers by 2040 [61] 2. **Satellite Deployment**: Starlink has launched over 10,000 satellites, with approximately 9,400 currently operational [47] 3. **Market Position**: Starlink is positioned to fill the gap in global internet connectivity, with a focus on underserved regions [51] Technological Advancements 1. **Rocket Technology**: SpaceX's Falcon 9 and Starship rockets are designed for high payload capacities and reusability, significantly reducing launch costs [43][26] 2. **Engine Development**: The Raptor engine's performance improvements will lower the cost per kilogram for orbital launches [28][29] 3. **Starship's Future**: Starship is expected to transport millions of tons of goods to Mars, with the first unmanned mission planned in collaboration with the Italian Space Agency [37][38] Market Trends 1. **Rocket Launch Market Growth**: The global rocket launch market is entering a high-growth phase, driven by demand for low Earth orbit satellite networks [19] 2. **LEO Satellite Dominance**: Low Earth Orbit (LEO) satellites are becoming the dominant technology for satellite internet, with significant advantages over traditional ground-based communications [17] Additional Insights 1. **Vertical Integration**: SpaceX has established a highly integrated industrial system, managing everything from component production to multi-orbit launch delivery [24] 2. **Collaborative Ecosystem**: The integration of Starlink with Tesla and xAI enhances the overall value proposition, creating a robust data transmission network [11][12] This summary encapsulates the key insights from the SpaceX conference call, highlighting the company's ambitious plans, financial outlook, technological advancements, and market positioning.
Robex Resources (OTCPK:RSRB.F) 2025 Extraordinary General Meeting Transcript
2025-12-30 14:02
Summary of Robex Resources Extraordinary General Meeting Company Overview - **Company**: Robex Resources (OTCPK: RSRB.F) - **Meeting Date**: December 30, 2025 - **Location**: Virtual meeting Key Points Discussed Meeting Structure and Participation - The meeting was conducted virtually to enhance accessibility and encourage shareholder participation regardless of geographic location [2][5] - A quorum was established with 50 shareholders represented by proxy, totaling 202,437,829 shares, which is 73.55% of the issued and outstanding shares [5] Agenda Items - The primary agenda item was the special resolution to approve a statutory plan of arrangement between Robex Resources, Predictive Discovery Limited, and 9548-5991 Quebec Inc. [3][11] - The management information circular and related documents were made available to shareholders prior to the meeting [4] Voting Procedures - Shareholders and proxy holders were allowed to vote online, with the requirement that at least two-thirds of the votes cast were needed to pass the arrangement resolution [9][10] - The voting process was facilitated through an online platform, allowing registered shareholders to change their votes if desired [11] Voting Results - The arrangement resolution was approved with a significant majority, receiving 94.54% of the votes in favor [17][22] Conclusion of Meeting - The meeting concluded with the resolution adopted, and a motion was made to officially close the meeting [22][26] Additional Important Information - The company emphasized the importance of maintaining order during the meeting and reserved the right to limit questions to ensure broad participation [6][7] - Shareholders were encouraged to submit questions relevant to the agenda items, with a limit on the number of questions per participant to facilitate discussion [6][8] This summary encapsulates the key aspects of the Robex Resources Extraordinary General Meeting, highlighting the company's commitment to shareholder engagement and the successful passage of the proposed arrangement resolution.
OceanFirst Financial (NasdaqGS:OCFC) M&A Announcement Transcript
2025-12-30 14:02
OceanFirst Financial Corp and Flushing Financial Corp Merger Conference Call Summary Industry and Company Overview - **Companies Involved**: OceanFirst Financial Corp (NasdaqGS:OCFC) and Flushing Financial Corp - **Industry**: Banking and Financial Services - **Transaction Type**: All-stock merger valued at approximately $579 million Key Points and Arguments Merger Announcement - OceanFirst and Flushing Financial have entered into a definitive agreement to merge, with Flushing Bank merging into OceanFirst Bank as the surviving entity [4][2] - The merger aims to create a high-performing regional bank with a significant presence in the Northeast [4] Strategic Rationale - The merger supports OceanFirst's growth strategy in New York, where it has been expanding since 2019, now holding $2.2 billion in loans and over $800 million in deposits in the market [5] - The combined entity will have approximately $23 billion in assets, $17 billion in loans, and $18 billion in deposits, with around 70 branches [6] Market Positioning - The merger positions OceanFirst as the second-largest bank in the Long Island deposit market among banks with less than $50 billion in assets [6] - The transaction enhances the distribution network and branding presence, which would have taken years to achieve organically [5] Financial Projections - Expected pro forma return on average assets of approximately 1% and return on tangible common equity of approximately 13% by 2027 [10] - Anticipated EPS accretion of approximately 16% in 2027, with tangible book value dilution of just 6.4% [10] - Cost savings projected at 35% of Flushing's non-interest expenses, with full realization expected by 2027 [18] Capital Investment - A strategic capital investment of $225 million from Warburg Pincus will strengthen capital levels and support future growth [7] - OceanFirst shareholders will own approximately 58% of the combined company, Flushing shareholders 30%, and Warburg Pincus 12% [7] Credit Quality and Risk Management - Both companies have a strong record of credit quality, with Flushing's average net charge-offs at only seven basis points over the past decade [11] - The merger will allow for a conservative approach to managing the combined commercial real estate portfolio, with plans to optimize and potentially sell certain loans [14][59] Operational Integration - OceanFirst has a strong history of successful M&A execution, having completed eight whole bank acquisitions and eight core conversions in the past decade [21] - Key management from Flushing will be retained to ensure a smooth integration process [21] Additional Important Insights - The merger is expected to enhance profitability through scale and improved financial performance compared to standalone operations [8] - The combined company will leverage Flushing's established presence in attractive markets, which would have taken significant investment to replicate [12] - The transaction is anticipated to receive regulatory approval in the first half of 2026, with a closing expected in the second quarter [20] Market Dynamics - The merger allows for a mixed shift in deposit growth strategies, focusing on reducing reliance on higher-cost funding sources and enhancing non-interest-bearing deposits [34][46] - The combined franchise is expected to improve its competitive position against larger banks by offering a comprehensive suite of products with the responsiveness of a regional bank [36] Future Outlook - The focus will remain on continual growth in commercial and industrial lending, enhancing treasury management capabilities, and improving branch performance across key markets [16] - The merger is seen as a strategic move to accelerate growth and improve profitability while maintaining a strong capital position [19][10]